Seniors and Alzheimer’s Disease: Early Detection

Seniors and Alzheimer’s Disease: Early Detection

Posted on August 2, 2013 by ECR Louisville in Alzheimers Care, Blog, Caregiver Education, Dementia Care, Memory Loss

Do you know that you could be under 65 and still have Alzheimer’s Disease? Early Alzheimer’s affects roughly 200,000 Americans and accounts for 5-10% of all Alzheimer’s cases. Unlike other forms of the disease, this type generally runs in families and is linked to three separate genes.                        

You may choose to get pre-screened for early onset Alzheimer’s if you have parents or grandparents who suffered from this disease before age 65. Learning about Alzheimer’s is the first step toward managing its progression.
Alzheimer’s drug treatments aren’t an option for every family that encounters early Alzheimer’s, whether it’s for cost reasons or an adversity to artificial chemicals. In this case, support systems and group therapy are important for bolstering coping skills. It will be difficult to adjust to the new attitudes that will likely emerge.
“It’s not him, it’s just the disease progressing,” which is what Alzheimer’s caregivers will have to repeatedly tell themselves. They will also need some treatment to detect other incommunicable problems — like urinary tract infections, fevers or vision loss — that may be manifested through odd behavior.
The US-FDA has approved two types of medication to deal with the cognitive effects of early onset Alzheimer’s Disease. The first type is Cholinesterase (KOH-luh-NES-ter-ays) inhibitors, which work by preventing the breakdown of the chemical messengers responsible for learning and memory.
This medication may delay worsening of symptoms for 6 to 12 months for half the people who take them. To treat Alzheimer’s symptoms, there are three inhibitors commonly prescribed: Galantamine (Razadyne), Rivastigmine (Exelon) and Donepezil (Aricept).

The second US-FDA approved early onset Alzheimers treatment is Memantine (Nameda), which works by regulating glutamate activity. Glutamate is a different chemical messenger involved in learning and memory and is affected more in the moderate to severe cases. Experts say that this drug helps with naming abilities and functional communication; however, they add that there is currently no significant treatment that can reverse or completely halt the degeneration.
“The longer you wait, the more impaired you become,” says Stephen McConnell, senior vice president of the Alzheimer’s Association. He adds that many people don’t realize they have early Alzheimer’s before it’s too late. Poor financial decisions like giving away large donations to telemarketers, is one of the first symptoms of early onset Alzheimer’s.
Writing checks, balancing checkbooks and basic addition may suddenly become difficult. In the early stages of Alzheimer’s, patients feel foggy and confused constantly, often placing items in strange locations (like keys in the icebox) and substituting odd words in sentences. While there is no cure, an early diagnosis is important because it allows the family time to discuss and plan their future before the disease progresses.

About the Author

Enrich your knowledge further about early Alzheimer’s treatment from Mike Selvon portal. We appreciate your feedback at our nursing care blog where a free gift awaits